As previously described [28], tumor cells were harvested and prepared in HBSS. For tail vein injection assays, 106 K7M2 cells or 104 MG63.3 cells were intravenously injected into 5–6-week-old female BALB/c or SCID-Beige mice. Mice were either treated at Day 2 after tumor cell injection (early treatment) or at Day 9, when the micro-metastases were established in the lungs (late treatment). Mice were randomly divided into four cohorts (the experiments were repeated 2–3 times with n = 3–9), receiving daily gavage of vehicle (HPBCD, twice/day), CB-839 (200 mg/kg, twice/day), metformin (300 mg/kg, once/day), or combination of CB-839 and metformin. The experiments were terminated after 30 consecutive days of treatment. Lungs of treated mice were inflated and formalin-fixed. The whole lung fluorescent images were acquired via fluorescent stereomicroscopy (Leica MGFLIII). The percent of the lung occupied by metastases area/total lung area was calculated with ImageJ software. Lung metastases were also examined using H&E stained paraffin-embedded sections. Statistical analysis was performed with GraphPad Prism.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.